The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients
Yıl: 2018 Cilt: 64 Sayı: 1 Sayfa Aralığı: 72 - 79 Metin Dili: İngilizce DOI: 10.5606/tftrd.2018.1068 İndeks Tarihi: 08-07-2020
The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients
Öz: Objectives: This study aims to evaluate the effect of blood glucose regulation on sarcopenia parameters in sarcopenic, obese, and poorly-regulated diabetic patients.Patients and methods: Between June 2013 and December 2013, a total of 147 patients (64 males, 83 females; mean age 70.3±6.3 years; range,60 to 90 years) who were diagnosed with sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP)criteria were included in the study. All patients were obese with a body mass index (BMI) of >30 kg/m 2 and their glycated hemoglobin(HbA1c) levels were above 8%. Sarcopenia parameters including the gait speed, muscle strength, muscle mass, and handgrip strength wereassessed. After a six-month treatment period, the patients were divided into two groups according to their HbA1c levels as having <8% or>8%. Sarcopenia parameters were evaluated before and after receiving treatment.Results: The mean disease duration was 16±6.2 years. Sixty patients were found to have a HbA1c level of <8% and 45 patients with a HbA1clevel of ≥8% at sixth months of follow-up. In better regulated group, sarcopenia parameters such as gait speed, muscle mass, and handgripstrength improved; however, only the change in the muscle mass was found to be statistically significant (p=0.041). There was no significantchange in the parameters of sarcopenia in the patient group with a HbA1c level ≥8%. A negative correlation was found between the musclemass and HbA1c levels in good- and poorly-regulated groups (p=0.039 r:-0.327 and p=0.044 r:-0.183, respectively).Conclusion: Our study demonstrates that lowering HbA1c levels may have positive effects on the muscle mass even in diabetic and sarcopenicobese elderly individuals.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Wang C, Bai L. Sarcopenia in the elderly: basic and clinical issues. Geriatr Gerontol Int 2012;12:388-96.
- Andrade F. Estimating diabetes and diabetes-free life expectancy in Mexico and seven major cities in Latin America and the Caribbean. Rev Panam Salud Publica 2009;26:9-16.
- Cho EH, Shin D, Cho KH, Hur J. Prevalences and Management of Diabetes and Pre-diabetes among Korean Teenagers and Young Adults: Results from the Korea National Health and Nutrition Examination Survey 2005- 2014. J Korean Med Sci 2017;32:1984-90.
- Ho PJ, Turtle JR. Establishing the Diagnosis. In: Sinclair AJ, Finucane P, editors. Diabetes in Old Age. 2nd ed. Chichester: John Wiley & Sons; 2000. p. 00-00.
- Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging 2010;5:217-28.
- Rosenberg IH, Roubenoff R. Stalking sarcopenia. Ann Intern Med 1995;123:727-8.
- Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-63.
- Elia M. Obesity in the elderly. Obes Res 2001;9 Suppl 4:244S-248S.
- An KO, Kim J. Association of Sarcopenia and Obesity With Multimorbidity in Korean Adults: A Nationwide Cross- Sectional Study. J Am Med Dir Assoc 2016;17:960.e1-7.
- Ruiz-Arregui L, Castillo-Martínez L, Orea-Tejeda A, Mejía- Arango S, Miguel-Jaimes A. Prevalence of self-reported overweight-obesity and its association with socioeconomic and health factors among older Mexican adults. Salud Publica Mex 2007;49:482-7.
- Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes 2004;53:1543-8.
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23.
- Fragala MS, Alley DE, Shardell MD, Harris TB, McLean RR, Kiel DP, et al. Comparison of handgrip and leg extension strength in predicting slow gait speed in older adults. J Am Geriatr Soc 2016;64:144-50.
- Available from: https://explorable.com/statistical- correlation
- Charlton M, Nair KS. Protein metabolism in insulin- dependent diabetes mellitus. J Nutr 1998;128:323-7.
- Karakelides H, Asmann YW, Bigelow ML, Short KR, Dhatariya K, Coenen-Schimke J, et al. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects. Diabetes 2007;56:2683-9.
- Halvatsiotis P, Short KR, Bigelow M, Nair KS. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002;51:2395-404.
- Gougeon R, Morais JA, Chevalier S, Pereira S, Lamarche M, Marliss EB. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 2008;31:128-33.
- Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 2008;57:56-63.
- Denne SC, Brechtel G, Johnson A, Liechty EA, Baron AD. Skeletal muscle proteolysis is reduced in noninsulin- dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J Clin Endocrinol Metab 1995;80:2371-7.
- Ohsawa M, Murakami T, Kume K. Possible involvement of insulin resistance in the progression of cancer cachexia in mice. Yakugaku Zasshi 2016;136:687-92. [Abstract]
- Fujita S, Glynn EL, Timmerman KL, Rasmussen BB, Volpi E. Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. Diabetologia 2009;52:1889-98.
- Kaushik S, Singh R, Cuervo AM. Autophagic pathways and metabolic stress. Diabetes Obes Metab 2010;12:4-14.
- Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006;147:4160-8.
- Nilsson MI, Dobson JP, Greene NP, Wiggs MP, Shimkus KL, Wudeck EV, et al. Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity. FASEB J 2013;27:3905-16.
- Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, et al. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy- specific gene transcription. Proc Natl Acad Sci U S A 2006;103:16260-5.
- Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51:2944-50.
- Jerusalem F, Engel AG, Peterson HA. Human muscle fiber fine structure: morphometric data on controls. Neurology 1975;25:127-34.
- Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsøe R, Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 2007;50:790-6.
- Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003;100:8466-71.
- Lira VA, Benton CR, Yan Z, Bonen A. PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol Endocrinol Metab 2010;299:145-61.
- Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, Beck-Nielsen H, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007;56:1592-9.
- Phielix E, Mensink M. Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol Behav 2008;94:252-8.
- Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 2003;100:7996-8001.
- Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI- matched control subjects. Diabetologia 2007;50:113-20.
- Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care 2007;30:1507-12.
- Newman AB, Haggerty CL, Goodpaster B, Harris T, Kritchevsky S, Nevitt M, et al. Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2003;51:323-30.
- Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol (1985) 2000;88:1321-6.
- Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, de Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009;32:1993-7.
- Park SW, Goodpaster BH, Strotmeyer ES, de Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 2006;55:1813-8.
- Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004;109:1729-34.
- Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57:326-32.
- Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010;33:1497-9.
- Kim JH, Cho JJ, Park YS. Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci 2015;30:264-71.
- Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011;96:2898-903.
- Tanaka K, Kanazawa I, Sugimoto T. Reduction in Endogenous Insulin Secretion is a Risk Factor of Sarcopenia in Men with Type 2 Diabetes Mellitus. Calcif Tissue Int 2015;97:385-90.
- Brandt C, Nielsen AR, Fischer CP, Hansen J, Pedersen BK, Plomgaard P. Plasma and muscle myostatin in relation to type 2 diabetes. PLoS One 2012;7:e37236.
- Murphy J, Chevalier S, Gougeon R, Goulet ÉD, Morais JA. Effect of obesity and type 2 diabetes on protein anabolic response to insulin in elderly women. Exp Gerontol 2015;69:20-6.
- Kwon SS, Lee SG, Lee YH, Lim JB, Kim JH. Homeostasis model assessment of insulin resistance in a general adult population in Korea: additive association of sarcopenia and obesity with insulin resistance. Clin Endocrinol (Oxf) 2017;86:44-51.
- Matulewicz N, Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online) 2016;70:1245-58.
- Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005;60:324-33.
- Mogi M, Kohara K, Nakaoka H, Kan-No H, Tsukuda K, Wang XL, et al. Diabetic mice exhibited a peculiar alteration in body composition with exaggerated ectopic fat deposition after muscle injury due to anomalous cell differentiation. J Cachexia Sarcopenia Muscle 2016;7:213-24.
- Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000;55:221-31.
- Newman AB, Simonsick EM, Naydeck BL, Boudreau RM, Kritchevsky SB, Nevitt MC, et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 2006;295:2018-26.
- Volpato S, Bianchi L, Lauretani F, Lauretani F, Bandinelli S, Guralnik JM, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care 2012;35:1672-9.
| APA | Öztürk Z, Turkbeyler I, DEMİR Z, BİLİCİ M, KEPEKÇİ Y (2018). The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. , 72 - 79. 10.5606/tftrd.2018.1068 |
| Chicago | Öztürk Zeynel Abidin,Turkbeyler Ibrahim Halil,DEMİR ZEYNEP,BİLİCİ Muhammet,KEPEKÇİ Yalçın The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. (2018): 72 - 79. 10.5606/tftrd.2018.1068 |
| MLA | Öztürk Zeynel Abidin,Turkbeyler Ibrahim Halil,DEMİR ZEYNEP,BİLİCİ Muhammet,KEPEKÇİ Yalçın The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. , 2018, ss.72 - 79. 10.5606/tftrd.2018.1068 |
| AMA | Öztürk Z,Turkbeyler I,DEMİR Z,BİLİCİ M,KEPEKÇİ Y The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. . 2018; 72 - 79. 10.5606/tftrd.2018.1068 |
| Vancouver | Öztürk Z,Turkbeyler I,DEMİR Z,BİLİCİ M,KEPEKÇİ Y The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. . 2018; 72 - 79. 10.5606/tftrd.2018.1068 |
| IEEE | Öztürk Z,Turkbeyler I,DEMİR Z,BİLİCİ M,KEPEKÇİ Y "The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients." , ss.72 - 79, 2018. 10.5606/tftrd.2018.1068 |
| ISNAD | Öztürk, Zeynel Abidin vd. "The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients". (2018), 72-79. https://doi.org/10.5606/tftrd.2018.1068 |
| APA | Öztürk Z, Turkbeyler I, DEMİR Z, BİLİCİ M, KEPEKÇİ Y (2018). The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turkish Journal of Physical Medicine and Rehabilitation, 64(1), 72 - 79. 10.5606/tftrd.2018.1068 |
| Chicago | Öztürk Zeynel Abidin,Turkbeyler Ibrahim Halil,DEMİR ZEYNEP,BİLİCİ Muhammet,KEPEKÇİ Yalçın The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turkish Journal of Physical Medicine and Rehabilitation 64, no.1 (2018): 72 - 79. 10.5606/tftrd.2018.1068 |
| MLA | Öztürk Zeynel Abidin,Turkbeyler Ibrahim Halil,DEMİR ZEYNEP,BİLİCİ Muhammet,KEPEKÇİ Yalçın The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turkish Journal of Physical Medicine and Rehabilitation, vol.64, no.1, 2018, ss.72 - 79. 10.5606/tftrd.2018.1068 |
| AMA | Öztürk Z,Turkbeyler I,DEMİR Z,BİLİCİ M,KEPEKÇİ Y The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turkish Journal of Physical Medicine and Rehabilitation. 2018; 64(1): 72 - 79. 10.5606/tftrd.2018.1068 |
| Vancouver | Öztürk Z,Turkbeyler I,DEMİR Z,BİLİCİ M,KEPEKÇİ Y The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients. Turkish Journal of Physical Medicine and Rehabilitation. 2018; 64(1): 72 - 79. 10.5606/tftrd.2018.1068 |
| IEEE | Öztürk Z,Turkbeyler I,DEMİR Z,BİLİCİ M,KEPEKÇİ Y "The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients." Turkish Journal of Physical Medicine and Rehabilitation, 64, ss.72 - 79, 2018. 10.5606/tftrd.2018.1068 |
| ISNAD | Öztürk, Zeynel Abidin vd. "The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients". Turkish Journal of Physical Medicine and Rehabilitation 64/1 (2018), 72-79. https://doi.org/10.5606/tftrd.2018.1068 |
